The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT

Gene. 2014 Feb 25;536(2):348-56. doi: 10.1016/j.gene.2013.11.072. Epub 2013 Dec 12.

Abstract

Background: A variant of the ether-à-go-go related channel (hERG), p.Arg148Trp (R148W) was found at heterozygous state in two infants who died from sudden infant death syndrome (SIDS), one with documented prolonged QTc and Torsade de Pointes (TdP), and in an adult woman with QTc >500 ms, atrioventricular block and TdP. This variant was previously reported in cases of severe ventricular arrhythmia but very rarely in control subjects. Its classification as mutation or polymorphism awaited electrophysiological characterization.

Methods: The properties of this N-terminal, proximal domain, hERG variant were explored in Xenopus oocytes injected with the same amount of RNA encoding for either hERG/WT or hERG/R148W or their equimolar mixture. The human ventricular cell (TNNP) model was used to test the effects of changes in hERG current.

Results: R148W alone produced a current similar to the WT (369 ± 76 nA (mean ± SEM), n=13 versus 342 ± 55 nA in WT, n=13), while the co-expression of 1/2 WT+1/2 R148W lowered the current by 29% versus WT (243 ± 35 nA, n=13, p<0.05). The voltage dependencies of steady-state activation and inactivation were not changed in the variant alone or in co-expression with the WT. The time constants of fast recovery from inactivation and of fast and slow deactivation analyzed between -120 and +20 mV were not changed. The voltage-dependent distribution of the current amplitudes among fast-, slow- and non-deactivating fractions was unaltered. A 6.6% increase in APD90 from 323.5 ms to 345 ms was observed using the human cardiac ventricular myocyte model.

Conclusions: Such a decrease in hERG current as evidenced here when co-expressing the hERG/R148W variant with the WT may have predisposed to the observed long QT syndrome and associated TdP. Therefore, the heterozygous carriers of hERG/R148W may be at risk of cardiac sudden death.

Keywords: APD; APD at 90% repolarization; APD90; Action potential duration; Arrhythmias; Channelopathy; Cyclic DNA; DNA; Deoxyribonucleic acid; ECG; ESP; Electrocardiogram; Exome Sequencing Project; HEK293; Human ether-à-go-go related channel; Human ether-à-go-go related gene; Human-derived renal epithelial cell line number 293; IKr; LQTS; Long QT syndrome; Messenger RNA; Mutation; PAS domain; Per-Arnt-Sim domain in the N-terminal branch of the hERG protein; QT; QTc; RNA; RR; Ribonucleic acid; SCD; SDS; SEM; SIDS; SSCP; Single-strand conformational polymorphism; Sodium dodecyl-sulfate; Standard error of the mean; Sudden cardiac death; Sudden death; Sudden infant death syndrome; TNNP; TdP; Ten Tusscher, Noble, Noble and Panfilov (2004), mathematical model of a human ventricular action potential; The QT interval of the ECG; The RR interval of the ECG; The corrected QT interval of the ECG, using Bazett's formula; The rapid delayed rectifier current, underlied in cardiac cells by hERG; Torsade de pointes; WT; Wild-type; cDNA; hERG; mRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Arrhythmias, Cardiac / genetics*
  • Arrhythmias, Cardiac / metabolism
  • Brugada Syndrome
  • Cardiac Conduction System Disease
  • Cell Line
  • Death, Sudden, Cardiac
  • Female
  • HEK293 Cells
  • Heart / physiopathology
  • Heart Conduction System / abnormalities*
  • Heart Conduction System / metabolism
  • Heterozygote
  • Humans
  • Infant
  • Long QT Syndrome / genetics*
  • Long QT Syndrome / metabolism
  • Male
  • Mutation / genetics*
  • Myocytes, Cardiac / metabolism
  • Oocysts / metabolism
  • Trans-Activators / genetics*
  • Trans-Activators / metabolism
  • Transcriptional Regulator ERG
  • Xenopus / genetics
  • Xenopus / metabolism

Substances

  • ERG protein, human
  • Trans-Activators
  • Transcriptional Regulator ERG